Rich Jones

Rich Jones is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as the VP and Head of Global Business Strategy & Analytics at Daiichi Sankyo, Inc. since June 2021. In this role, Rich leads teams in Market Research, Forecasting, Pipeline Strategy, Competitive Intelligence, and Investor Relations, particularly within the Global Oncology Business Unit. Previously, Rich held the position of US Hematology BIA Lead at Bristol Myers Squibb, overseeing a team managing insights and analytics for a portfolio exceeding $14 billion. Rich's experience also includes serving as Division CFO at Celgene, where responsibilities encompassed Business Planning & Operations and Financial Planning & Analysis, as well as significant roles at Daiichi Sankyo in Business Development and Portfolio Management. Rich began a career at Novartis as the Director of Strategy & Operations. Educational credentials include a BS in Pharmacy from Northeastern University, an MBA in Finance from Seton Hall University, and executive education programs at Columbia University and Harvard University, focused on business and oncology.